MMP9 and CCL18 associate with chronic urticaria while type I, IV, and VI collagens change with omalizumab treatment

Ewa A Bartko; Maiken Mellergaard; Solveig S Groen; Signe Holm Nielsen; Jesper Elberling; Aase Handberg; Lars K Poulsen; Lars H Blom; Bettina M Jensen

doi:10.1111/all.16212

MMP9 and CCL18 associate with chronic urticaria while type I, IV, and VI collagens change with omalizumab treatment

Ewa A Bartko, Maiken Mellergaard, Solveig S Groen, Signe Holm Nielsen, Jesper Elberling, Aase Handberg, Lars K Poulsen, Lars H Blom, Bettina M Jensen

Allergi, Hud- og Kønssygdomme

Originalsprog	Engelsk
Tidsskrift	Allergy
Vol/bind	79
Udgave nummer	9
Sider (fra-til)	2558-2561
Antal sider	4
ISSN	0105-4538
DOI	https://doi.org/10.1111/all.16212
Status	Udgivet - sep. 2024

Adgang til dokumentet

10.1111/all.16212

Andre filer og links

Link to publication in Scopus

Citationsformater

@article{1b88f4cdf32a49bda3458d0b958af9d1,

title = "MMP9 and CCL18 associate with chronic urticaria while type I, IV, and VI collagens change with omalizumab treatment",

keywords = "Humans, Omalizumab/therapeutic use, Chronic Urticaria/drug therapy, Matrix Metalloproteinase 9/metabolism, Anti-Allergic Agents/therapeutic use, Chemokines, CC/metabolism, Collagen/metabolism, Female, Male, Treatment Outcome",

author = "Bartko, {Ewa A} and Maiken Mellergaard and Groen, {Solveig S} and Nielsen, {Signe Holm} and Jesper Elberling and Aase Handberg and Poulsen, {Lars K} and Blom, {Lars H} and Jensen, {Bettina M}",

year = "2024",

month = sep,

doi = "10.1111/all.16212",

language = "English",

volume = "79",

pages = "2558--2561",

journal = "Allergy",

issn = "0105-4538",

publisher = "Wiley-Blackwell Publishing Ltd",

number = "9",

}

TY - JOUR

T1 - MMP9 and CCL18 associate with chronic urticaria while type I, IV, and VI collagens change with omalizumab treatment

AU - Bartko, Ewa A

AU - Mellergaard, Maiken

AU - Groen, Solveig S

AU - Nielsen, Signe Holm

AU - Elberling, Jesper

AU - Handberg, Aase

AU - Poulsen, Lars K

AU - Blom, Lars H

AU - Jensen, Bettina M

PY - 2024/9

Y1 - 2024/9

KW - Humans

KW - Omalizumab/therapeutic use

KW - Chronic Urticaria/drug therapy

KW - Matrix Metalloproteinase 9/metabolism

KW - Anti-Allergic Agents/therapeutic use

KW - Chemokines, CC/metabolism

KW - Collagen/metabolism

KW - Female

KW - Male

KW - Treatment Outcome

UR - http://www.scopus.com/inward/record.url?scp=85197258150&partnerID=8YFLogxK

U2 - 10.1111/all.16212

DO - 10.1111/all.16212

M3 - Journal article

C2 - 38953463

SN - 0105-4538

VL - 79

SP - 2558

EP - 2561

JO - Allergy

JF - Allergy

IS - 9

ER -